603896 Zhejiang Shouxiangu Pharmaceutical
- 26.30
- -0.69-2.56%
Zhejiang Shouxiangu Pharmaceutical News
Shou Xian Valley (603896.SH): No cooperation with Zhejiang Hospital of Traditional Chinese Medicine on Wu Mei Soup
Gelonghui, May 27丨Shouxiangu (603896.SH) said on the investor interactive platform that the company has yet to cooperate with Zhejiang Hospital of Traditional Chinese Medicine on Wumei Soup.
Shouxianggu (603896.SH): Did not participate in this Shenzhou 17 space flight test
Gelonghui, May 7, 丨 Shouxiangu (603896.SH) said on the investor interactive platform that the company carried out six space breeding work in 2003, 2005, 2012, 2013, 2016 and 2021, respectively, and did not participate in this Shenzhou 17 space launch test.
Shouxianggu (603896.SH): Net profit of 77.132 million yuan in the first quarter increased 23.19% year-on-year
On April 25, Ge Longhui (603896.SH) released its report for the first quarter of 2024, achieving operating income of 221 million yuan, up 7.15% year on year; net profit attributable to shareholders of listed companies of 77.132 million yuan, up 23.19% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of 68.1435 million yuan, an increase of 22.30% year on year; basic earnings per share of 0.39 yuan.
While Shareholders of Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Are in the Red Over the Last Year, Underlying Earnings Have Actually Grown
The simplest way to benefit from a rising market is to buy an index fund. While individual stocks can be big winners, plenty more fail to generate satisfactory returns. That downside risk was realiz
Could The Market Be Wrong About Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHSE:603896) Given Its Attractive Financial Prospects?
It is hard to get excited after looking at Zhejiang Shouxiangu Pharmaceutical's (SHSE:603896) recent performance, when its stock has declined 18% over the past three months. However, stock prices ar
Shousengoku (603896.SH): Third-generation deswalled Ganoderma lucidum spore powder product has health benefits to enhance immunity
Gelonghui, March 13 | Shouxianggu (603896.SH) said on the investor interactive platform that the key to preventing viral infections is to improve autoimmunity. The company's third-generation Ganoderma lucidum spore powder products have health benefits to enhance immunity.
Shouxiangoku (603896.SH): Live streaming with live and AI characters has been implemented alternately on the JD platform
Gelonghui, February 22丨Shouxiangu (603896.SH) said on the investor interactive platform that the company cooperated with Chengdu Bozhiweixun Information Technology Co., Ltd. on a digital marketing system development project, not a marketing promotion project. The project is currently being carried out in an orderly manner. Currently, the company has implemented an alternating live broadcast of live and AI characters on the JD platform.
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s (SHSE:603896) Prospects Need A Boost To Lift Shares
With a price-to-earnings (or "P/E") ratio of 17.8x Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHSE:603896) may be sending bullish signals at the moment, given that almost half of all companies in C
Shou Xian Valley (603896.SH): Entered the Alibaba International website and Amazon platform, and currently sales are still small
Gelonghui, January 30丨Shouxiangu (603896.SH) said on the investor interactive platform that currently, the company has just set up overseas markets and entered the Alibaba International website and Amazon platform respectively, and sales are still relatively small. In the future, the company will gradually expand overseas markets.
Shouxiangoku (603896.SH): There are currently no plans to issue or transfer shares in a targeted manner
On January 23, Gelonghui | Shouxiangu (603896.SH) said on the investor interactive platform that the company has no plans to issue or transfer shares in a targeted manner for the time being. If there is a relevant plan, the company will fulfill its information disclosure obligations in strict accordance with the relevant regulations. Please continue to pay attention to the company's announcements.
Shousengoku (603896.SH): Ganoderma lucidum has been included in the food substance list and can be used as a food ingredient
Gelonghui, January 17丨Shou Xian Gu (603896.SH) said on the investor interactive platform that Ganoderma lucidum fruiting bodies and Ganoderma lucidum spore powder belong to different medicinal parts of Ganoderma lucidum. There are certain differences in composition and efficacy, and each has its own advantages. At present, the company has scientifically combined traditional Chinese medicines such as Ganoderma lucidum, Ganoderma lucidum spore powder, ginseng, and gynostemma for health functions such as enhancing immunity, aiding in lowering blood lipids, reducing fatigue, and protecting the liver, and has developed a variety of health foods that are easy to take, such as tablets, capsules, and oral liquid. Pharmacodynamics studies have shown remarkable results. In addition, Ganoderma lucidum has been included in the food quality list, but
The Total Return for Zhejiang Shouxiangu Pharmaceutical (SHSE:603896) Investors Has Risen Faster Than Earnings Growth Over the Last Five Years
While Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHSE:603896) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 26% in the
Shouxianggu (603896.SH): The main reason for the increase in sales in the fourth quarter was the fourth quarter and the first quarter were the company's peak sales seasons, and dealers needed to increase their stocking volume
Gelonghui, January 3 | Shouxiangu (603896.SH) said on the investor interactive platform that in recent years, the company's accounts receivable have shown an upward trend, mainly due to the increase in the company's sales revenue and the increase in retail outlets during the reporting period. The company has formulated strict accounts receivable management measures and credit ratings for dealers. The account period is 1-3 months. The dealer franchise model adopted in 2020 all uses payment methods of payment first, then goods, and the probability that accounts receivable cannot be recovered is extremely low. The main reason for the increase in sales in the fourth quarter was that the fourth quarter and the first quarter were peak sales seasons for the company, and dealers needed to increase their stocking volume.
Shouxiangu (603896.SH): Subsidiary obtained domestic health food registration certificate
Glonghui on December 15 | Shouxiangu (603896.SH) announced that the wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd., the “Shouxiangu Brand Red Yeast Ganoderma lucidum capsule” product has completed the domestic health food registration process and obtained a domestic health food registration certificate issued by the State Administration of Market Supervision and Administration.
Shouxiangu (603896.SH): Saffron series products still account for a small share of revenue
Glonghui, December 12|Shouxiangu (603896.SH) said on the investor interactive platform that saffron, also known as saffron, is a precious traditional Chinese herbal medicine that has the effects of activating blood circulation, cooling blood, detoxification, and relieving anxiety; it is used for menstrual cramps, post-natal stasis, mild poisoning, depression, and panic. Currently, the company has 2 types of saffron products: dried saffron flower (Chinese medicine tablets) and Shouxiangu brand saffron tin maple cream (health food). Shouxiangu brand saffron tin maple cream is a scientific combination of motherwort, dendrobium officinale, poria cocos, American ginseng, and saffron. It has a health-care function that enhances immunity, and is mainly used for health care that enhances immunity.
Shouxiangu (603896.SH): The overall sales scale of sub-brands such as Wu Xiang and Shouxian Shangpin is still small
Glonghui December 6 | Shouxiangu (603896.SH) said on the investor interactive platform that currently, in addition to the “Shouxiangu” main brand, the company also has sub-brands such as “Wu Xiang”, “Wu Xiang Wan Yan”, “Golden Crane Wan Yan”, “Shouxian Premium”, “Shouxian Materia Medica”, “Shouxian Materia Medica”, “Shouxiantang”, and “Pule Baihao”. Take Ganoderma lucidum spore powder as an example. The “Shouxiangu” brand spore powder is the third-generation Ganoderma lucidum spore powder. It is positioned high-end and targets the middle and high-end customer groups; other sub-brand spore powders are the second generation of common wall-breaking Ganoderma lucidum spore powder, which is positioned as affordable and targets ordinary consumers. In addition to the middle and high-end markets, Ling
Shouxiangu (603896.SH): “Wuxiang Wanyan Brand Ganoderma lucidum spore powder” completed the filing of domestic health food
Shouxiangu (603896.SH) issued an announcement. Recently, Jinhua Shouxiangu Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company...
Shouxiangu (603896.SH): Douyin promotion and sales have already started
Gelonghui November 23|Shouxiangu (603896.SH) said on the investor interactive platform that the company has already started promoting and selling on Douyin.
Shouxiangu (603896.SH): Research on the anti-tumor effects and mechanisms of Ganoderma lucidum spore powder is currently being carried out with the Chinese Society of Traditional Chinese Medicine
Shouxiangu (603896.SH) issued an announcement. The company called at the Shanghai Stock Exchange Roadshow Center on November 15, 2023...
[BT Financial Report Instantaneous Analysis] Shouxiangu 2023 Quarterly Report: Net profit is growing steadily, and the business model of the whole industry chain helps improve performance
This financial report was announced on 2023-10-26 15:40:32 Shouxiangu (stock code: 603896) is a national high-tech enterprise specializing in the selection, cultivation, processing and sales of precious Chinese herbal medicines. The company's core products include Shouxiangu brand Ganoderma lucidum spore powder (broken wall), broken wall Ganoderma lucidum spore powder particles, broken wall Ganoderma lucidum spore powder, iron maple bucket granules, and iron maple leaf ganoderma lucidum extract. Adhering to the business tenet of “innovating modern biotechnology, cultivating rare medicinal herbs, extracting the essence of Chinese medicine, and serving people's health and longevity”, the company is committed to providing high-quality Chinese medicine tablets and health care
Analysis
Price Target
No Data
